Firebrick Pharma Limited (ASX: FRE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0560
+0.0020 (3.70%)
Dec 20, 2024, 3:45 PM AEST

Firebrick Pharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Market Capitalization
12112745--
Market Cap Growth
-59.96%-59.96%-38.95%---
Enterprise Value
11102241--
Last Close Price
0.060.060.150.27--
PS Ratio
3.653.981211.4541.30--
PB Ratio
5.175.1711.035.40--
P/TBV Ratio
5.175.1711.035.40--
EV/Sales Ratio
3.983.50993.5237.40--
Debt / Equity Ratio
-----0.14
Asset Turnover
1.021.020.000.210.35-
Quick Ratio
6.106.104.9218.277.753.11
Current Ratio
7.197.195.1118.507.773.12
Return on Equity (ROE)
-51.22%-51.22%-126.49%-77.28%-251.89%-
Return on Assets (ROA)
-25.33%-25.33%-72.06%-41.82%-126.25%-
Return on Capital (ROIC)
-29.73%-29.73%-78.47%-44.65%-153.17%-
Earnings Yield
-11.73%-10.75%-24.90%-8.48%--
FCF Yield
-19.93%-21.44%-21.18%-9.46%--
Buyback Yield / Dilution
-5.25%-5.25%-45.98%-5.45%-265.19%-
Total Shareholder Return
-5.25%-5.25%-45.98%-5.45%-265.19%-
Source: S&P Capital IQ. Standard template. Financial Sources.